ReviewCureus2026
Recovery-Primed Stimulation: A Proposed Framework for Controlled Triggering of Healing-Related Physiology in Low-Grade Chronic Inflammation.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-grade chronic inflammation (LGCI) is considered a heterogeneous, persistent, high-burden biological state rather than a single disease entity. In LGCI, inflammation-related pathways can reinforce each other, creating a self-sustaining inflammatory state. This creates a treatment-design problem: stimulation delivered into LGCI biology that is already primed by persistent inflammatory drivers and has not fully returned to a resolved resting state may produce the expected, wanted biological effects, such as braking, resolution, repair, or regulatory recovery, but may also worsen LGCI by adding inflammatory drive to already active inflammatory pathway loops. This unwanted effect may include nuclear factor kappa B (NF-κB) or inflammasome reactivation, cytokine-loop amplification, flare response, increased autonomic-inflammatory pressure, temporal summation, or adverse carryover. Recovery-primed stimulation (RP) is a proposed framework for controlled triggering of healing-related physiology followed by recovery-compatible repetition. In RP, a biochemical, biophysical, or combined input is used as a controlled trigger of wanted healing-related physiology, and repetition is delayed until the induced wanted response has had time to unfold and unwanted carryover is absent or acceptable. The hypothesis is that RP may better fit LGCI physiology than dense repetition and may improve the balance between wanted and unwanted effects. RP extends this controlled-triggering and recovery-compatible-repetition logic across biochemical, biophysical, or combined inputs and across multiple LGCI-relevant target pathway axes. It is presented as an interdisciplinary technology platform for controlled biological triggering in low-threshold, slow-recovery biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.